Overview
- 186 inspections across 177 sites are on record.
- 323 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-08-06.
At a glance
Inspections
186
Sites
177
Observations
323
Career since
Sep 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| LGM Pharma Solutions, LLC. | 6 Aug 2025 | Human Drugs | On file |
| Melaleuca Inc | 14 May 2025 | Human Drugs | On file |
| OHM Pharma, Inc. | 29 Apr 2025 | Human Drugs | On file |
| Viyash Life Sciences Private Limited | 16 Feb 2024 | Human Drugs | On file |
| Admiron Life Sciences Pvt. Ltd. | 9 Feb 2024 | Human Drugs | On file |
Sites inspected
LGM Pharma Solutions, LLC.Rosenberg, United States1 insp.
Melaleuca IncKnoxville, United States1 insp.
OHM Pharma, Inc.Mineral Wells, United States1 insp.
Viyash Life Sciences Private LimitedVisakhapatnam, India1 insp.
Admiron Life Sciences Pvt. Ltd.Paravada, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Craig P Seaborn17 shared
Samuel A Hamblin13 shared
Susan M Taylor10 shared
Thomas J Prigge9 shared
Holly J Wilson6 shared
Andrew I Carr6 shared
Darren S Morgan6 shared
Andrew J Lang5 shared
Michael E Campbell5 shared
Rafael E Arroyo4 shared
Full investigator report
Get the verbatim findings behind Nadeem I Chaudhry's 323 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site